Exenatide LAR Phase III Non-Inferiority Data Anticipated In Q4, Amylin Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is also on track to finalize commercial manufacturing for the once weekly form of Byetta in the second half of 2008.